Double-blind, placebo-controlled trial of the use of lithium to augment 
antidepressant medication in continuation treatment of unipolar major 
depression.

Bauer, M.; Bschor, T.; Kunz, D.; Berghöfer, A.; Ströhle, A.; Müller-Oerlinghausen, B.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.

MPS-Authors

Bauer, M.
Max Planck Institute of Psychiatry, Max Planck Society;

Bschor, T.
Max Planck Institute of Psychiatry, Max Planck Society;

Kunz, D.
Max Planck Institute of Psychiatry, Max Planck Society;

Berghöfer, A.
Max Planck Institute of Psychiatry, Max Planck Society;

Ströhle, A.
Max Planck Institute of Psychiatry, Max Planck Society;

Müller-Oerlinghausen, B.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Bauer, M., Bschor, T., Kunz, D., Berghöfer, A., Ströhle, A., & Müller-Oerlinghausen, B. (2000). Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. American Journal of Psychiatry, 157, 1429-1435.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-A4B0-B

Abstract

There is no abstract available